Kumar Rajesh, Das Anupam, Das Sudip
Department of Dermatology, Grant Medical College, Mumbai, Maharashtra, India.
Department of Dermatology, KPC Medical College, Kolkata, West Bengal, India.
Indian J Dermatol. 2018 Mar-Apr;63(2):117-124. doi: 10.4103/ijd.IJD_583_17.
Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are severe cutaneous adverse reactions, which are mainly caused by drugs; and these are usually associated with high degree of morbidity and mortality. Recently, two detailed guidelines were published on the management of SJS/TEN, Indian guidelines and UK guidelines. Still, there is no consensus on the management of SJS/TEN. In this article, our aim is to conceptualize the management aspect of SJS/TEN considering Indian setup. Early discontinuation of all medicines, supportive measures (hydration, electrolytes, and care of denuded skin), corticosteroids and cyclosporine has been found to be useful. Oral provocation test is reserved for patients, who undergo complete remission and this is to be done after hospitalization, under strict vigilance. As there is no consensus, the treatment should be individualized on case to case basis.
史蒂文斯-约翰逊综合征(SJS)和中毒性表皮坏死松解症(TEN)是严重的皮肤不良反应,主要由药物引起;通常伴有高发病率和死亡率。最近,关于SJS/TEN的管理发布了两份详细指南,即印度指南和英国指南。然而,对于SJS/TEN的管理仍未达成共识。在本文中,我们的目的是结合印度的情况,对SJS/TEN的管理方面进行概念化阐述。已发现尽早停用所有药物、采取支持措施(补液、电解质及对裸露皮肤的护理)、使用皮质类固醇和环孢素是有用的。口服激发试验仅适用于完全缓解的患者,且应在住院后、严格监测下进行。由于尚未达成共识,治疗应根据具体病例进行个体化处理。